Professor Chak-sing Lau

Vice-President and Pro-Vice-Chancellor (Health)
Dean of Medicine, The University of Hong Kong
Chair & Daniel CK Yu Professor in Rheumatology and Clinical Immunology
Immediate Past President, Hong Kong Academy of Medicine

Title

Transforming Healthcare through Collaboration, Innovation and Research Excellence

Abstract

Research collaboration between faculties within the university is essential in today's dynamic healthcare landscape if we want to achieve impactful innovations and cutting-edge solutions to modern healthcare challenges. In this modern era of the fifth industrial revolution in medical education, the rapid development of artificial intelligence (AI), big data and biomedical technologies have given rise to exciting new opportunities for interdisciplinary research opportunities. We must tap into these emerging technologies to ensure that we evolve and train fit-for-purpose healthcare scientists to meet the needs of modern healthcare challenges which are often multi-dimensional and complex. It is only through the adoption of a holistic and synergistic approach to the research endeavours of all the university’s faculties can we successfully harness the full transformative power of collaboration and innovation to advance healthcare solutions for future generations.

Biography

Professor CS Lau is an international expert in rheumatology. He presided over the Hong Kong Academy of Medicine (2016-2020); the Asia-Pacific League of Associations for Rheumatology (2006); the Hong Kong Society of Rheumatology (1997-2001). He founded the Hong Kong Arthritis & Rheumatism Foundation (2001) and was a member of the Outcomes in Rheumatology, European League Against Rheumatism (EULAR) Scientific Committee. He is an expert advisor to the HKSAR Government on multiple health-related policies and was appointed a member of the 14th National Committee of the Chinese People’s Political Consultative Conference (CPPCC) representing the health sector, and a member of the 14th Beijing Municipal Committee of the CPPCC in 2023. His research interests include systemic lupus erythematosus, rheumatoid arthritis, and related disorders. He is listed in the world’s top 2% most cited scientists by Stanford University and has published over 450 articles and delivered more than 350 presentations. He is on the editorial board of many peer-reviewed journals.